36 related articles for article (PubMed ID: 15767210)
1. Development of an enzyme-linked immunosorbent assay (ELISA) for the specific detection of MEKK1 expression in cells.
Ding Y; Huang D; Chen XG
J Pharmacol Toxicol Methods; 2005; 51(2):159-67. PubMed ID: 15767210
[TBL] [Abstract][Full Text] [Related]
2. Depleting MEKK1 expression inhibits the ability of invasion and migration of human pancreatic cancer cells.
Su F; Li H; Yan C; Jia B; Zhang Y; Chen X
J Cancer Res Clin Oncol; 2009 Dec; 135(12):1655-63. PubMed ID: 19513748
[TBL] [Abstract][Full Text] [Related]
3. Dominant negative MEKK1 inhibits survival of pancreatic cancer cells.
Hirano T; Shino Y; Saito T; Komoda F; Okutomi Y; Takeda A; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Oncogene; 2002 Aug; 21(38):5923-8. PubMed ID: 12185592
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
[TBL] [Abstract][Full Text] [Related]
5. Negative regulation of MEKK1/2 signaling by serine-threonine kinase 38 (STK38).
Enomoto A; Kido N; Ito M; Morita A; Matsumoto Y; Takamatsu N; Hosoi Y; Miyagawa K
Oncogene; 2008 Mar; 27(13):1930-8. PubMed ID: 17906693
[TBL] [Abstract][Full Text] [Related]
6. MEKK1-induced apoptosis is mediated by Smac/Diablo release from the mitochondria.
Mendoza FJ; Henson ES; Gibson SB
Biochem Biophys Res Commun; 2005 Jun; 331(4):1089-98. PubMed ID: 15882989
[TBL] [Abstract][Full Text] [Related]
7. The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase.
Cross JV; Foss FW; Rady JM; Macdonald TL; Templeton DJ
BMC Cancer; 2007 Sep; 7():183. PubMed ID: 17894894
[TBL] [Abstract][Full Text] [Related]
8. MEK kinase 1 is a negative regulator of virus-specific CD8(+) T cells.
Labuda T; Christensen JP; Rasmussen S; Bonnesen B; Karin M; Thomsen AR; Odum N
Eur J Immunol; 2006 Aug; 36(8):2076-84. PubMed ID: 16761309
[TBL] [Abstract][Full Text] [Related]
9. MEKK1 interacts with alpha-actinin and localizes to stress fibers and focal adhesions.
Christerson LB; Vanderbilt CA; Cobb MH
Cell Motil Cytoskeleton; 1999; 43(3):186-98. PubMed ID: 10401575
[TBL] [Abstract][Full Text] [Related]
10. The c-Jun N-terminal kinase cascade plays a role in stress-induced apoptosis in Jurkat cells by up-regulating Fas ligand expression.
Faris M; Kokot N; Latinis K; Kasibhatla S; Green DR; Koretzky GA; Nel A
J Immunol; 1998 Jan; 160(1):134-44. PubMed ID: 9551965
[TBL] [Abstract][Full Text] [Related]
11. MEKK1 induces c-Jun complexes that act as negative regulators for cell survival and proliferation of HCC cells.
Komoda F; Shino Y; Hirano T; Okutomi Y; Okamoto H; Hayashi Y; Suyama T; Ebara M; Saisho H; Shirasawa H
Int J Oncol; 2002 Sep; 21(3):553-9. PubMed ID: 12168099
[TBL] [Abstract][Full Text] [Related]
12. Activation of MEKK1 by Rho GTPases.
Chen Z; Cobb MH
Methods Enzymol; 2006; 406():468-78. PubMed ID: 16472679
[TBL] [Abstract][Full Text] [Related]
13. Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Rangaswami H; Kundu GC
Oncol Rep; 2007 Oct; 18(4):909-15. PubMed ID: 17786354
[TBL] [Abstract][Full Text] [Related]
14. A cryptic tubulin-binding domain links MEKK1 to curved tubulin protomers.
Filipčík P; Latham SL; Cadell AL; Day CL; Croucher DR; Mace PD
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21308-21318. PubMed ID: 32817551
[TBL] [Abstract][Full Text] [Related]
15. Survival regulation in pancreatic cancer cells by c-Jun.
Okutomi Y; Shino Y; Komoda F; Hirano T; Ishihara T; Yamaguchi T; Saisho H; Shirasawa H
Int J Oncol; 2003 Oct; 23(4):1127-34. PubMed ID: 12963995
[TBL] [Abstract][Full Text] [Related]
16. MEKK1 controls matrix degradation and tumor cell dissemination during metastasis of polyoma middle-T driven mammary cancer.
Cuevas BD; Winter-Vann AM; Johnson NL; Johnson GL
Oncogene; 2006 Aug; 25(36):4998-5010. PubMed ID: 16568086
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin 1 receptor modulates the MEKK1-induced c-Jun trans-activation: structural requirements of the receptor.
Ibarz G; Oiry C; Carnazzi E; Crespy P; Escrieut C; Fourmy D; Galleyrand JC; Gagne D; Martinez J
Br J Pharmacol; 2006 Apr; 147(8):951-8. PubMed ID: 16491099
[TBL] [Abstract][Full Text] [Related]
18. MEKK1-induced apoptosis requires TRAIL death receptor activation and is inhibited by AKT/PKB through inhibition of MEKK1 cleavage.
Bild AH; Mendoza FJ; Gibson EM; Huang M; Villanueva J; Garrington TP; Jove R; Johnson GL; Gibson SB
Oncogene; 2002 Sep; 21(43):6649-56. PubMed ID: 12242663
[TBL] [Abstract][Full Text] [Related]
19. [Role of human telomerase reverse transcriptase in apoptosis of human umbilical vein endothelial cells induced by trichostatin A].
Wu P; Xi L; Chen G; Wang BB; Luo DF; Lu YP; Zhou JF; Ma D
Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):334-7. PubMed ID: 17892126
[TBL] [Abstract][Full Text] [Related]
20. Kinase MEKK1 is required for CD40-dependent activation of the kinases Jnk and p38, germinal center formation, B cell proliferation and antibody production.
Gallagher E; Enzler T; Matsuzawa A; Anzelon-Mills A; Otero D; Holzer R; Janssen E; Gao M; Karin M
Nat Immunol; 2007 Jan; 8(1):57-63. PubMed ID: 17143273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
